The largest database of trusted experimental protocols

14 protocols using recombinant human scf

1

Culture and Purification of Mast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
LAD-2 cells were cultured as described (Kirshenbaum et al., 2003 (link); Radinger et al., 2010 ) in StemPro-34 medium containing 13 ml of StemPro-34 Nutrient Supplement and l-glutamine (2 mM) and penicillin (100 U/ml)/streptomycin (100 μg/ml; all from GIBCO, Grand Island, NY) with 100 ng/ml recombinant human SCF added (Peprotech, Rocky Hill, NJ). Half of the medium supplemented with SCF was changed every 7 d. HLMCs were obtained by lung resection for bronchial carcinoma and purified using immunoaffinity magnetic selection using anti-CD117 (BD Biosciences, San Jose, CA) as described (Sanmugalingam et al., 2000 (link)) and were cultured as described (Cruse et al., 2008 (link)). All human subjects gave written informed consent, and the study was approved by the Leicestershire Research Ethics Committee, United Kingdom. Human peripheral blood–derived mast cells were cultured from CD34+ progenitors as described (Radinger et al., 2010 ). The donors provided an informed consent, and cells were obtained under a protocol (NCT00001756) approved by the National Institute of Allergy and Infectious Diseases, National Institutes of Health Internal Review Board.
+ Open protocol
+ Expand
2

Culture and Characterization of LAD2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The LAD2 cell line (a gift from Arnold Kirshenbaum and Dean Metcalfe from the National Institutes of Health, NIAID) was cultured in StemPro-34 SFM media (Life Technologies, Burlington, ON, Canada) supplemented with 2mM L-glutamine, 100 U/ml penicillin, 50 mg/ml streptomycin, and 100 ng/ml recombinant human SCF (Peprotech, Rocky Hill, NJ, USA). Cells were maintained at 1×105 cells/ml at 37°C and 5% CO2 and periodically tested for the expression of CD117 (eBioscience, Invitrogen Carlsbad, CA, USA), and FcϵRI (eBioscience, Invitrogen Carlsbad, CA, USA) by flow cytometry using a CytoFlex flow cytometer (Beckman Coulter, Brea, CA, USA).
+ Open protocol
+ Expand
3

MRGPRX2-Mediated Mast Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell culture reagents and DNP-specific mouse IgE (SPE-7) were purchased from Invitrogen (Carlsbad, CA, USA). Recombinant murine interleukin-3 (IL-3), stem cell factor (SCF), and recombinant human SCF were purchased from Peprotech (Rocky Hill, NJ, USA). DNP-BSA and p-nitrophenyl-N-acetyl-β-D-glucosamine (PNAG) were from Sigma-Aldrich (St. Louis, MO, USA), Compound 48/80 was from AnaSpec (Fremont, CA, USA). Amaxa transfection kit (Kit V) was purchased from Lonza (Gaithersburg, MD, USA). PE anti-human MRGPRX2 antibody was purchased from Biolegend (San Diego, CA, USA). Polyclonal MRGPRX2 Ab was purchased from Novus Biologicals (Littleton, CO, USA). HRP-conjugated anti-rabbit IgG was from Cell Signaling Technologies (Danvers, MA, USA). West Pico Chemiluminescent Substrate was from Thermo Scientific (Rockford, IL, USA). DNeasy Blood and Tissue Kit was purchased from Qiagen (Germantown, MD, USA). QuikChange II Site-Directed Mutagenesis Kit was purchased from Agilent Genomics (Santa Clara, CA, USA). Plasmid encoding hemagglutinin (HA)-tagged human MRGPRX2 in pReceiver-MO6 vector was obtained from GeneCopoeia (Rockville, MD, USA). Antimicrobial peptidomimetics (compound 1, compound 2, compound 3, compound 4, and compound 5) were obtained from Fox Chase Chemical Diversity Center (Doylestown, PA, USA).
+ Open protocol
+ Expand
4

Culturing Human Mast Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HMC-1.1 and HMC-1.2 human mast cell lines were cultured in Iscove's Modified Dulbecco's Medium (Lonza, Mississauga, ON, Canada) containing 10% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin. Cells were maintained at 1  ×  105 cells/ml at 37°C and 5% CO2. The LAD2 cell line was cultured in StemPro-34 SFM media (Life Technologies, Burlington, ON, Canada) supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 50 mg/ml streptomycin, and 100 ng/ml recombinant human SCF (Peprotech, Rocky Hill, NJ). Cells were maintained at 1  ×  105 cells/ml at 37°C and 5% CO2 and periodically tested for expression of KIT and FcεRI by flow cytometry. The cells were used within 8 weeks of thawing from cryopreservation.
+ Open protocol
+ Expand
5

Culturing Primary Mouse Fibroblasts and Hematopoietic Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary mouse embryonic fibroblasts MEFs were generated and cultured according to standard protocols [45 (link)]. The Erythroid Myeloid Lymphoid (EML) cell line described previously [22 (link)] was maintained in Iscove's Modified Dulbecco's Medium (IMDM), 20% fetal bovine serum (FBS), Glutamax, penicillin-streptomycin supplemented with 100 ng/mL recombinant murine SCF (Peprotech). Human cell lines K562 [46 (link)] and M07e [27 (link)] were maintained in RPMI-1640 with glutamine and HEPES (Invitrogen), 10% FBS, penicillin-streptomycin. M07e were supplemented with 100 ng/mL recombinant human SCF and 30 ng/mL GM-CSF (Peprotech).
+ Open protocol
+ Expand
6

Hematopoietic Growth Factor Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human SCF, IL-3 and EPO were from Peprotech (Hamburg, Germany). Insulin solution, holo-transferrin, heparin, hydrocortisone, bovine albumin, crystal violet, and DEAE-Dextran were from Sigma/Aldrich (Schnelldorf, Germany). MgCl2, CaCl2, NaHCO3, and formaldehyde were from Carl Roth (Karlsruhe, Germany).
+ Open protocol
+ Expand
7

Culturing LAD2 Human Mast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The LAD2 human mast cell line (38 (link)), was maintained in StemPro-34 SMF with supplement (Invitrogen, Carlsbad, CA) supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin (Sigma-Aldrich, St. Louis, MO) and recombinant human SCF (100 ng/ml, PeproTech, Rocky Hill, NJ).
+ Open protocol
+ Expand
8

Erythroid Differentiation of Transfected CD34+ HSPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfected CD34+ HSPCs were differentiated into mature RBCs using a three-phase erythroid differentiation protocol, as previously described12 (link),65 (link). During the first phase (day 0 to day 6), cells were cultured in a basal erythroid medium supplemented with 100 ng/ml recombinant human SCF (PeproTech), 5 ng/ml recombinant human IL-3 (PeproTech), 3 IU/ml EPO Eprex (Janssen-Cilag) and 10−6 M hydrocortisone (Sigma). During the second phase (day 6 to day 9), cells were co-cultured with MS-5 stromal cells in the basal erythroid medium supplemented with 3 IU/ml EPO Eprex (Janssen-Cilag). During the third phase (day 9 to day 20), cells were co-cultured with stromal MS-5 cells in a basal erythroid medium without cytokines. Heat-inactivated human AB serum was added during the third phase of the differentiation (10%; day 13 to day 20). Erythroid differentiation was monitored by flow cytometry analysis of CD36, CD71, GYPA, BAND3, and α4-Integrin erythroid surface markers and of enucleated cells using the DRAQ5 double-stranded DNA dye. 7AAD was used to identify live cells. The gating strategy used to assess erythroid surface markers and enucleated cells is shown in Supplementary Fig. 19.
+ Open protocol
+ Expand
9

High-Throughput Screening of MLL-AF9;FLT3-ITD Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MLL-AF9;FLT3-ITD cells were grown in Iscove’s modified Dulbecco’s medium (IMDM) (Thermo Fisher Scientific, catalog no. 12440-061) supplemented with 20% FBS (STEMCELLTechnologies, catalog no. 06100), 1% P/S (Thermo Fisher Scientific, catalog no. 15140122) with recombinant human SCF (PeproTech, catalog no. 300-07-50UG), recombinant human TPO (PeproTech, catalog no. 300-18-50UG), recombinant human FLT3 ligand (FL) (PeproTech, catalog no. 300-19-50UG), recombinant human IL-3 (PeproTech, catalog no. 200-03-50UG), and recombinant human IL-6 (PeproTech, catalog no. 200-06-50UG) (all at 10 ng/ml). MLL-AF9;FLT3-ITD cells were maintained in IMDM supplemented with 20% FBS and no growth factors. Cells were plated at a density of 500 cells per well in 5 μl of complete growth medium in 1536-well white tissue culture assay plates (Greiner). Compounds (23 nl) were then added to each assay plate using a PinTool Dispenser (Kalypsys). Plates were then covered with a stainless steel gasketed lid and placed into an incubator in 37°C and 5% CO2 for 48 hours. After this incubation, 3 μl of CellTiter-Glo reagent was added to each well and then incubated for 15 min at room temperature. Luminescence readings were taken using a ViewLux (PerkinElmer) with clear filter and a 2-s exposure time. Curve fitting was done using a four-parameter Hill slope equation (GraphPad Prism 7).
+ Open protocol
+ Expand
10

Generation of Human Mast Cells from CD34+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two hundred milliliter whole blood was drawn from each participant by venipuncture. Human mast cells were generated as previously described 9, 13. In brief, peripheral blood mononuclear cells were purified by lymphoprep™ density gradient separation (Axis‐Shield PoC, Oslo, Norway) and CD34+ hematopoietic stem cells were isolated from peripheral blood mononuclear cells by magnetic‐activated cell sorting using CD34 MicroBead Kit (Miltenyi Biotec, GmbH, Bergisch Gladbach, Germany) according to the manufacturer's instruction. Enriched CD34+ cells were cultured in StemPro®‐34 medium (Invitrogen, Carlsbad, CA) supplied with 100 ng/ml recombinant human SCF (PeproTech, Rocky Hill, NJ), 100 ng/ml recombinant human IL‐6 (PeproTech), 100 U/ml penicillin (Sigma–Aldrich, St Louis, MO), 100 μg/ml streptomycin and 2 mM L‐glutamine (Sigma–Aldrich). Recombinant human IL‐3 (30 ng/ml) (PeproTech) was included in the medium for the first week only. After 7–8 weeks of culture, the PBdMC were used for experiments. The purity of cultured PBdMC was assessed by toluidine blue staining and flow cytometry analysis and revealed >90% metachromatic stained cells and CD117+FcϵRI+ cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!